Lataa...
Blood neurofilament light chain as a biomarker of MS disease activity and treatment response
OBJECTIVE: To assess the value of blood neurofilament light chain (NfL) as a biomarker of recent, ongoing, and future disease activity and tissue damage and its utility to monitor treatment response in relapsing-remitting multiple sclerosis. METHODS: We measured NfL in blood samples from 589 patient...
Tallennettuna:
| Julkaisussa: | Neurology |
|---|---|
| Päätekijät: | , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Lippincott Williams & Wilkins
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6442011/ https://ncbi.nlm.nih.gov/pubmed/30737333 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1212/WNL.0000000000007032 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|